Inicio>>Peptides>>[Sar1, Ile8]-Angiotensin II TFA

[Sar1, Ile8]-Angiotensin II TFA (Synonyms: AngiotensinII TFA; Angiotensin 2 TFA)

Catalog No.GC35026

[Sar1, Ile8]-angiotensina II (TFA) es un péptido que tiene mÚltiples efectos sobre el mÚsculo liso vascular, incluida la contracciÓn de arterias normales y la hipertrofia o hiperplasia de células cultivadas o vasos enfermos.

Products are for research use only. Not for human use. We do not sell to patients.

[Sar1, Ile8]-Angiotensin II TFA Chemical Structure

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
122,00 $
Disponible
10mg
102,00 $
Disponible
50mg
389,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

[Sar1, Ile8]-Angiotensin II (TFA) is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.

[Sar1, Ile8]-Angiotensin II (TFA) has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels. [Sar1, Ile8]-Angiotensin II (TFA) activates both the NADPH and NADH oxidases, and stimulates superoxide anion formation in vascular smooth muscle cells[1].

[1]. Griendling KK, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994 Jun;74(6):1141-8.

Reseñas

Review for [Sar1, Ile8]-Angiotensin II TFA

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for [Sar1, Ile8]-Angiotensin II TFA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.